Vivione Biosciences collaborates on food-borne pathogens detection
Vivione's RAPID-B platform detection kit will include KPL's BacTrace affinity-purified primary antibodies. The platform uses flow cytometry combined with specific, proprietary reagents to provide food pathogen detection down to a single cell in seven hours. Most culture-based methods take up to 48 hours for detection.
"Vivione collaborated with the U.S. Food and Drug Administration's National Center for Toxicological Research over the past six years to accomplish the development and testing of the RAPID-B system," Kevin Kuykendall, the CEO of Vivione, said. "The strategic relationship with KPL enables us to immediately expand our product offerings and get to market much faster by leveraging their leadership expertise in antibody-based reagent production."
KPL develops antibodies for listeria, campylobacter, salmonella and food-borne pathogen detection. As part of the collaboration, Vivione will be able to leverage KPL's continuous stream of new products in development to detect emerging food-borne pathogens and infectious disease.
"The Vivione relationship is a perfect example of what we do best," Albert Perry, the CEO of KPL, said. "A significant portion of our business success stems from enabling our supply partners to accelerate commercialization with products that we are confident are robust and work the same way year after year. We are pleased to be part of the RAPID-B commercialization program and believe it will provide food manufacturers with the ability to reduce their time to results while providing more accurate information which can be used to reduce potential recalls and provide better consumer protection."
Vivione's business centers on commercializing the RAPID-B system, which consists of hardware, software and chemical reagents developed to test bacteria in certain environments.